Biotechnology Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings – Lumos Pharma (NASDAQ:LUMO) Read more
Biotechnology Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain & Function Results for Lorecivivint for Treatment of Knee Osteoarthritis at OARSI Conference, and Completion and Preliminary Analysis of OA-21 Trial 12-Week Pain Results Read more
Biotechnology Kamari Pharma Announces Abstracts Accepted for Presentation at the 81st Annual Meeting of the Society for Investigative Dermatology Read more
Biotechnology Scilex Holding Company Announces Acceptance Of Abstract For Poster And Oral Presentation At The Annual Meeting Of The American Academy Of Pain Medicine (AAPM) – Scilex Holding (NASDAQ:SCLX) Read more